Large-scale trials are only available for BH 4 , sepiapterin or sapropterin in phenylketonuria (Muntau et al., 2024), an autosomal recessive disorder caused by deficiency of phenylalanine hydroxylase, leading to hyperphenylalaninemia, developmental delay, behavioral problems, and reduced quality of life ( Approaches with preclinical evidence only Promoting transcriptional regulation of eNOS Several compounds have been identified to enhance eNOS transcription and promote NO production
benthamiana and were recovered in good yields as the pure proteins (Figure 2)
Therefore, in pharmacological management, it is essential not only to employ combination therapies to enhance dopaminergic signaling across multiple pathways and manage motor complications, but also to actively develop novel agents with multi-target profiles and explore treatments targeting non-dopaminergic systems that possess disease-modifying potential
Similar content being viewed by others Introduction The widespread misuse of alcohol poses a major global health threat, leading to profound social, economic, and medical consequences
